Medical Grade iPad Protection at Texas Children’s Hospital

UK-developed technology was showcased to staff at Texas Children’s Hospital who have since ordered 125

A pioneering iPad case that enables clinicians, patients and their families to use iPads without the risk of infection is being used at Texas Children’s Hospital.

Background

We’ve covered this one before, but thought an update was appropriate, especially as it’s one more success story from the Association of British Healthcare Industries’ (ABHI) recent mission to Texas. This is the story of FlipPad from UK-based FutureNova.

The device features an antimicrobial glass screen, which minimises the spread of health care-associated infections (HCAI). Effectively a specialised iPad “case” the FlipPad allows patients to watch a movie in the comfort of their bed. It also gives parents the opportunity to research their child’s condition, view their medical records and upcoming clinical regimes, as well as discuss their child’s health plan with clinicians. It can also be used with surgical gloves in any sterile environment.

The FlipPad was originally showcased in Texas last October as part of the medical technology (MedTech) mission. The missions have been organised by the Association of British Healthcare Industries (ABHI) – the industry association for the medical technology sector in the UK, to create stronger relationships between the UK and Texas.

Company comments

Mike Casey, CEO of FutureNova, said: “Using the iPad, gives patients and their families more information about the patient’s stay in the hospital and engages them in their care. FlipPad removes any issues of infection control as it can be cleaned using standard infection control sprays. It’s a great addition to the hospital for both patients and clinicians and we are delighted to be able to introduce it to Texas Children’s Hospital.”

 

Source: FutureNova

published: November 29, 2017 in: Products

Leave a Reply

Your email address will not be published. Required fields are marked *

Most read

Latest

^